Cosmo Pharmaceuticals N.V. (SIX: COPN), a global leader in AI-powered healthcare and specialty pharma, today announced that ColonPRO EU, the Company’s next-generation artificial intelligence software ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback